| Item Type | Name |
|
Concept
|
Alcoholic Intoxication
|
|
Concept
|
Alcoholism
|
|
Concept
|
Age Factors
|
|
Concept
|
Ethanol
|
|
Concept
|
Alkaline Phosphatase
|
|
Concept
|
Aging
|
|
Concept
|
Alcohols
|
|
Concept
|
Alcohol Drinking
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Biomechanical Phenomena
|
|
Concept
|
Injections, Intraperitoneal
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Enzyme Activation
|
|
Concept
|
Glioma
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Growth Plate
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Extremities
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Random Allocation
|
|
Concept
|
Mutation
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Humans
|
|
Concept
|
Weight Gain
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Gene Expression Regulation, Developmental
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Chondrocytes
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Indoleamine-Pyrrole 2,3,-Dioxygenase
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Mice
|
|
Concept
|
Glycogen Synthase Kinase 3
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Rats
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Tensile Strength
|
|
Concept
|
Blotting, Southern
|
|
Concept
|
DNA Methylation
|
|
Concept
|
In Situ Nick-End Labeling
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Compressive Strength
|
|
Concept
|
Immune Evasion
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
RANK Ligand
|
|
Concept
|
Aggrecans
|
|
Concept
|
Chickens
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
Cytokines
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Coculture Techniques
|
|
Academic Article
|
Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol.
|
|
Academic Article
|
Alcohol exposure and mechanisms of tissue injury and repair.
|
|
Academic Article
|
Acute alcohol exposure impairs fracture healing and deregulates ß-catenin signaling in the fracture callus.
|
|
Academic Article
|
Ketorolac administration does not delay early fracture healing in a juvenile rat model: a pilot study.
|
|
Academic Article
|
Aggrecan is required for growth plate cytoarchitecture and differentiation.
|
|
Academic Article
|
Exogenous activation of Wnt/ß-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.
|
|
Academic Article
|
The role of IDO in brain tumor immunotherapy.
|
|
Academic Article
|
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.
|
|
Academic Article
|
Advanced age negatively impacts survival in an experimental brain tumor model.
|
|
Academic Article
|
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
|
|
Academic Article
|
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma.
|
|
Academic Article
|
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.
|
|
Academic Article
|
IDO1 in cancer: a Gemini of immune checkpoints.
|
|
Academic Article
|
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
|
|
Academic Article
|
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.
|
|
Academic Article
|
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017).
|
|
Academic Article
|
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma.
|
|
Academic Article
|
The interplay among psychological distress, the immune system, and brain tumor patient outcomes.
|
|
Academic Article
|
Quantification of IDO1 enzyme activity in normal and malignant tissues.
|
|
Academic Article
|
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors.
|
|
Academic Article
|
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
|
|
Academic Article
|
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.
|
|
Academic Article
|
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.
|
|
Academic Article
|
Glioblastoma as an age-related neurological disorder in adults.
|
|
Academic Article
|
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.
|
|
Academic Article
|
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
|
|
Academic Article
|
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
|
|
Concept
|
Glycogen Synthase Kinase 3 beta
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Binge Drinking
|
|
Academic Article
|
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.
|
|
Academic Article
|
Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma.
|